These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 14623055)
1. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines. Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055 [TBL] [Abstract][Full Text] [Related]
2. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Li X; Okada Y; Pilbeam CC; Lorenzo JA; Kennedy CR; Breyer RM; Raisz LG Endocrinology; 2000 Jun; 141(6):2054-61. PubMed ID: 10830290 [TBL] [Abstract][Full Text] [Related]
3. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice. Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647 [TBL] [Abstract][Full Text] [Related]
4. Involvement of cyclo-oxygenase-2 in osteoclast formation and bone destruction in bone metastasis of mammary carcinoma cell lines. Ono K; Akatsu T; Murakami T; Kitamura R; Yamamoto M; Shinomiya N; Rokutanda M; Sasaki T; Amizuka N; Ozawa H; Nagata N; Kugai N J Bone Miner Res; 2002 May; 17(5):774-81. PubMed ID: 12009007 [TBL] [Abstract][Full Text] [Related]
5. Expression of messenger RNA for prostaglandin E receptor subtypes EP4/EP2 and cyclooxygenase isozymes in mouse periovulatory follicles and oviducts during superovulation. Segi E; Haraguchi K; Sugimoto Y; Tsuji M; Tsunekawa H; Tamba S; Tsuboi K; Tanaka S; Ichikawa A Biol Reprod; 2003 Mar; 68(3):804-11. PubMed ID: 12604629 [TBL] [Abstract][Full Text] [Related]
6. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Tomita M; Li X; Okada Y; Woodiel FN; Young RN; Pilbeam CC; Raisz LG Bone; 2002 Jan; 30(1):159-63. PubMed ID: 11792579 [TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury. Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357 [TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Sales KJ; Katz AA; Davis M; Hinz S; Soeters RP; Hofmeyr MD; Millar RP; Jabbour HN J Clin Endocrinol Metab; 2001 May; 86(5):2243-9. PubMed ID: 11344234 [TBL] [Abstract][Full Text] [Related]
9. Mouse mammary carcinoma cell line (BALB/c-MC) stimulates osteoclast formation from mouse bone marrow cells through cell-to-cell contact. Ono K; Akatsu T; Murakami T; Wada S; Nishikawa M; Kugai N; Yamamoto M; Matsuura N; Nagata N Bone; 1998 Jul; 23(1):27-32. PubMed ID: 9662127 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 acts via bone marrow macrophages to block PTH-stimulated osteoblast differentiation in vitro. Choudhary S; Blackwell K; Voznesensky O; Deb Roy A; Pilbeam C Bone; 2013 Sep; 56(1):31-41. PubMed ID: 23639875 [TBL] [Abstract][Full Text] [Related]
11. The mouse mammary tumor cell line, MMT060562, produces prostaglandin E2 and leukemia inhibitory factor and supports osteoclast formation in vitro via a stromal cell-dependent pathway. Akatsu T; Ono K; Katayama Y; Tamura T; Nishikawa M; Kugai N; Yamamoto M; Nagata N J Bone Miner Res; 1998 Mar; 13(3):400-8. PubMed ID: 9525340 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4. Chun KS; Akunda JK; Langenbach R Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329 [TBL] [Abstract][Full Text] [Related]
14. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma. Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477 [TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 is an enhancer of interleukin-1beta-induced expression of membrane-associated prostaglandin E synthase in rheumatoid synovial fibroblasts. Kojima F; Naraba H; Sasaki Y; Beppu M; Aoki H; Kawai S Arthritis Rheum; 2003 Oct; 48(10):2819-28. PubMed ID: 14558087 [TBL] [Abstract][Full Text] [Related]
16. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663 [TBL] [Abstract][Full Text] [Related]
17. Activation of EP4 receptors contributes to prostaglandin E2-mediated stimulation of renal sensory nerves. Kopp UC; Cicha MZ; Nakamura K; Nüsing RM; Smith LA; Hökfelt T Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1269-82. PubMed ID: 15292051 [TBL] [Abstract][Full Text] [Related]
18. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723 [TBL] [Abstract][Full Text] [Related]
19. Expression of COX-2 and PGE synthase and synthesis of PGE(2)in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Jabbour HN; Milne SA; Williams AR; Anderson RA; Boddy SC Br J Cancer; 2001 Sep; 85(7):1023-31. PubMed ID: 11592775 [TBL] [Abstract][Full Text] [Related]
20. Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2. Ono K; Akatsu T; Murakami T; Nishikawa M; Yamamoto M; Kugai N; Motoyoshi K; Nagata N J Endocrinol; 1998 Sep; 158(3):R1-5. PubMed ID: 9846175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]